🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Mediastinum Disease

SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma NCT05077527Phase 17 sites📍 Duarte📍 Chicago📍 New York AIDS Malignancy Consortium · Tests: Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T NCT06784726Phase 21 site📍 Seattle University of Washington · Tests: Odronextamab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Ther… Diagnosis and Comprehensive Treatment of Mediastinal Interventional Technique NCT06128681n/a1 site📍 Tianjin Dan Liu · Tests: Intraairway ultrasound-guided mediastinal opening technique, Transbronchial Lung Biopsy (TBLB) The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies NCT04329728Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Los Angeles AVM Biotechnology Inc · Tests: AVM0703 CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma NCT06026319Phase 11 site📍 Boston Marcela V. Maus, M.D.,Ph.D. · Tests: CD79b-19 CAR T cells, Cyclophosphamide, Fludarabine Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma NCT06536049Phase 1, Phase 23 sites📍 Minneapolis📍 Columbus📍 Richmond Yazeed Sawalha · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Epcoritamab Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy NCT06834373Phase 27 sites📍 Scottsdale📍 Jacksonville📍 Albert Lea Mayo Clinic · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Chimeric Antigen Receptor T-Cell Therapy, Computed … Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease NCT07685938Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Atorvastatin and Lisinopril, Placebo Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes NCT06921681NA1 site📍 Basel University of Zurich · Tests: Cryobiopsy of lymph nodes group 6 sec, Cryobiopsy lymphnode group 3 sec B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 NCT05518383Phase 41 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Cyclophosphamide, Cytarabine, Dexamethasone, Etoposide, Ifosfamide, Methotrexate, Cyclophosphamide, Cytarabine, Dexamet… A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies NCT07735533Phase 1, Phase 21 site📍 Nashville Umoja Biopharma · Tests: UB-VV400, Rapamycin (sirolimus) Mediastinal EBUS Cryobiopsy Study In Sweden NCT06347939n/a2 sites📍 Lund📍 Umeå Region Skane · Tests: Mediastinal lymph nodes cryobiopsies Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy NCT06238648Phase 26 sites📍 Rochester📍 St Louis📍 Hackensack Academic and Community Cancer Research United · Tests: Biopsy, Biospecimen Collection, Computed Tomography, Epcoritamab, Magnetic Resonance Imaging Proton Therapy for Mediastinal Lymphoma (PROMLY) NCT07817641NA1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Proton therapy Establishing Prospective Mediastinal Tumor Database of PUMCH NCT06421805n/a1 site📍 Beijing Peking Union Medical College Hospital SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009) NCT04527419NA1 site📍 Shanghai Fudan University · Tests: No mediastinal lymph node dissection Validation of an AI-Assisted Mediastinal EUS System for Training Improvement: a Prospective, Multi-Center, Randomized Trial NCT06790108NA1 site📍 Changsha The Third Xiangya Hospital of Central South University · Tests: Artificial intelligence device Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma NCT06464861Phase 11 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: CD19-CAR-NK/T Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma NCT05633615Phase 295 sites📍 Tucson📍 Tucson📍 Fayetteville SWOG Cancer Research Network · Tests: Axicabtagene Ciloleucel, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) NCT07225439Phase 12 sites📍 Cleveland📍 Cleveland Paolo Caimi, MD · Tests: Allogeneic NK cells, Rituximab, Tafasitamab, Interleukin-2, Fludarabine/cyclophosphamide Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients NCT07473167Phase 1, Phase 21 site📍 Seoul TICAROS Co., Ltd. · Tests: TC011 Bio-CAR-T BS Study NCT05366569n/a1 site📍 Brescia Azienda Socio Sanitaria Territoriale degli Spedali Civili d… Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors NCT05934084NA40 sites📍 Ancona📍 Aviano📍 Bari Fondazione Italiana Linfomi - ETS · Tests: Lifestyles Implemented-Survivorship Care Plan (LS-SCP) Immunotherapy in Lymphoma NCT06796517n/a2 sites📍 Seoul📍 Seoul Sung-Soo Park · Tests: CAR-T Therapy, Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody, Proteasome Inhibitor Clinical Research on a Novel Deep-learning Based System in Mediastinal Endoscopic Ultrasound Scanning NCT05792280NA1 site📍 Changsha The Third Xiangya Hospital of Central South University · Tests: AI system CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies NCT04186520Phase 1, Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: 8/12-Day Production of Car-T Cells, 8/12-Day Production of Cryopreserved Car-T Cells, 12-Day Production of Car-T Cells Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers NCT05940272NA2 sites📍 New York📍 New York Memorial Sloan Kettering Cancer Center · Tests: Hematolo-GIST Training, Participants Appointment Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19) NCT06533579Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Vironexis Biotherapeutics Inc. · Tests: Dose Level 1, VNX-101, Dose Level 2, VNX-101, Dose Level 3, VNX-101, Dose Level 4, VNX-101 Tubeless VATS for Mediastinal Neoplasm NCT07065604NA1 site📍 Guangzhou Shuben Li · Tests: Non-intubated VATS for mediastinal neoplasm, Intubated VATS for mediastinal neoplasm
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy